Olanzapine pamoate
Product Description
Inke S.A.
-
ES
-
2017On CPHI since
-
100 - 249Employees
Company types
Categories
Inke S.A.
-
ES
-
2017On CPHI since
-
100 - 249Employees
Company types
More Products from Inke S.A. (45)
-
Product Imidapril
Inke (API manufacturer) part of Neuraxpharm, provides wide range of APIs which includes Imidapril. Indication: Hypertension
EU DMF -
Product Indacaterol maleate
Inke (API manufacturer) part of Neuraxpharm, provides wide range of APIs which includes Indacaterol. Indications Asthma and COPD
EU and US DMF available -
Product Loratadine
Inke (API manufacturer) part of Neuraxpharm, provides wide range of APIs which includes Loratadine. Indication: Allergy
JP DMF
-
Product Montelukast sodium
Inke (API manufacturer) part of Neuraxpharm, provides wide range of APIs which includes Montelukast sodium. Indication: Asthma, allergic and seasonal rhinitis
EU and JP DMF -
Product Nitrendipine
Inke (API manufacturer) part of Neuraxpharm, provides wide range of APIs which includes Nitrendipine. Indication: Hypertension
CEP an DMF
-
Product Olanzapine
Inke (API manufacturer) part of Neuraxpharm, provides wide range of APIs which includes Olanzapine. Indications: Schizophrenia, psychosis
EU and US DMF
-
Product Olodaterol
Inke (API manufacturer) part of Neuraxpharm, provides wide range of APIs which includes Olodaterol. Indication COPD -
Product Ondansetron base
Inke (API manufacturer) part of Neuraxpharm, provides wide range of APIs which includes Ondansetron base. Indication: Emesis
EU-US DMF -
Product Ondansetron hydrochloride
Inke (API manufacturer) part of Neuraxpharm, provides wide range of APIs which includes Ondansetron hydrochloride. Indication: Emesis
CEP and US DMF -
Product Prasugrel base
Inke (API manufacturer) part of Neuraxpharm, provides wide range of APIs which includes Prasugrel base. Indication: Prophylaxis and therapy of thrombosis
EU DMF -
Product Quetiapine hemifumarate
Inke (API manufacturer) part of Neuraxpharm, provides wide range of APIs which includes Quetiapine hemifumarate. Indication: Schizophrenia, psychosis
JP and KR DMF -
Product Revefenacin
Inke (API manufacturer) part of Neuraxpharm, provides wide range of APIs which includes Revefenacin for COPD treatment
Inke S.A. resources (1)
-
Brochure INKE PORTFOLIO AND PIPELINE
Inke is a Barcelona-based company with an FDA approved plant, we develop and manufacture APIs with complex synthesis process mostly for Respiratory diseases (Inhalation) and also CNS , among other therapeutically areas.
INKE has several DMFs approved already in the US-FDA and we are already supplying to some local and multinational pharmaceutical companies worldwide.
Position your company at the heart of the global Pharma industry with a CPHI Online membership
-
Your products and solutions visible to thousands of visitors within the largest Pharma marketplace
-
Generate high-quality, engaged leads for your business, all year round
-
Promote your business as the industry’s thought-leader by hosting your reports, brochures and videos within your profile
-
Your company’s profile boosted at all participating CPHI events
-
An easy-to-use platform with a detailed dashboard showing your leads and performance